Sana Biotechnology Inc vs Yum! Brands, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Yum! Brands, Inc. trades at $148 (market cap $40.62B). The key difference: Yum! Brands, Inc. is far larger — about 46.5× Sana Biotechnology Inc's market cap, and Yum! Brands, Inc. pays a 2.04% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | YUM | |
|---|---|---|
Market Cap | $873.84M | $40.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $168.16 |
52-Week Low | $2.68 | $138.21 |
Enterprise Value | $848.03M | $51.88B |
Dividend Yield | — | 2.04% |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →